²úÆ·¹©Ó¦·úÂÞɳÐÇ

  • ·¢²¼ÈÕÆÚ£º2024-05-07
  • ÓÐЧÆÚÏÞ£º30Ìì
ºþ±±ºãÂÌÔ´¿Æ¼¼ÓÐÏÞ¹«Ë¾ VIP
C17H18F3N3O3
369.3383

ÏêϸÐÅÏ¢
  • ;6,8-¶þ·ú-1-(2-·úÒÒ»ù)-1,4-¶þÇâ-7-(4-¼×»ù-1-ßßົù)-4-Ñõ-3-à­ßøôÈËá;
  • Fleroxacin
  • ;6,8-difluoro-1-(2-fluoroethyl)-1,4-dihydro-7-(4-methylpiperazino)-4-oxo-3-quinolinecarboxylic acid;6,8-difluoro-1-(2-fluoroethyl)-7-(4-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;6,8-Difluoro-1-(2-Fluoroethyl)-1,4-Dihydro-7-(4-Methyl-1-Piperazinyl)-4-Oxo-3-Quinolinecarboxylic Acid;
  • InChI=1/C17H18F3N3O3/c1-21-4-6-22(7-5-21)15-12(19)8-10-14(13(15)20)23(3-2-18)9-11(16(10)24)17(25)26/h8-9H,2-7H2,1H3,(H,25,26)
  • 1.409g/cm3
  • 535.3¡ãC at 760 mmHg
  • 277.6¡ãC

ÃâÔðÉùÃ÷£ºÒÔÉÏËùչʾµÄÐÅÏ¢ÓÉÆóÒµ×ÔÐÐÌṩ£¬ÄÚÈݵÄÕæʵÐÔ¡¢×¼È·ÐԺͺϷ¨ÐÔÓÉ·¢²¼ÆóÒµ¸ºÔ𣬻¯¹¤Íø¶Ô´Ë²»³Ðµ£Èκα£Ö¤ÔðÈΡ£ÎÒÃÇÔ­ÔòÉϽ¨ÒéÄúÑ¡Ôñ»¯¹¤Íø¸ß¼¶»áÔ±»òVIP»áÔ±¡£